|
|
 |
Brazil's regulatory authority, the National Health
Surveillance Agency (ANVISA), was created in 1999 with the aim to
protect and promote the population's health and to ensure the safety
of products and services.
 Health
Care System
Brazil, with a population of about 180 million, is the largest and
most populous country in South America. This enormous population
offers significant advantages for recruiting patients for clinical
trials, due to the ethnic diversity and the large number of treatment-naive
patients within the population.
Healthcare facilities vary widely from region to region. Brazil
has several state-of-the-art hospitals, in particular in Sao Paulo
and Rio de Janeiro, two of the largest cities in the world. A growing
number of well-qualified investigators with knowledge of ICH guidelines
and GCP standards are available.
The healthcare system is two-tiered. All Brazilian citizens are
entitled to free medical assistance through the Unified Health System,
SUS (Sistema Único de Saúde). Those who can afford
it have access to the private healthcare sector, which complements
the public healthcare services and covers about 25% of the population.
Authorities
Ministry of Health
National
Health Surveillance Agency, ANVISA (Agencia Nacional de Vigiláncia
Sanitária)
|
|
|
|
|
BRAZIL
